Clinical Research

At Avisi Technologies, our focus is on bringing innovative, safe, and effective glaucoma treatments to patients. Clinical research plays a critical part in this effort.  We believe that participating in clinical studies will contribute to advancements that will benefit others with similar conditions. Together, we can enhance healthcare for generations to come. 

The SAPPHIRE clinical trial has been approved. You can learn more about eligibility criteria and participating sites by visiting ClinicalTrials.gov.

Skip to content